[Experience with the combination of vincamine and papaverine in chronic brain syndrome].
D000368:Aged; D002545:Brain Ischemia / Q000188:drug therapy; D002561:Cerebrovascular Disorders / Q000150:complications / Q000188:drug therapy*; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D008297:Male; D001523:Mental Disorders / Q000209:etiology; D009069:Movement Disorders / Q000209:etiology; D010208:Papaverine / Q000008:administration & dosage* / Q000627:therapeutic use; D013064:Speech Disorders / Q000209:etiology; D014748:Vinca Alkaloids / Q000008:administration & dosage*; D014749:Vincamine / Q000008:administration & dosage* / Q000627:therapeutic use
D014748:Vinca Alkaloids; D014749:Vincamine; D010208:Papaverine
Esperienza con associazione di vincamina e papaverina nella "chronic brain syndrome".